Unknown

Dataset Information

The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease.


ABSTRACT:

Background

Patients with inflammatory bowel disease (IBD) are at increased risk for pneumonia, and corticosteroids are reported to amplify this risk. Less is known about the impact of corticosteroid-sparing IBD therapies on pneumonia risk or the efficacy of pneumococcal vaccination in reducing all-cause pneumonia in real-world IBD cohorts.

Methods

We performed a population-based study using an established Veterans Health Administration cohort of 29,957 IBD patients. We identified all patients who developed bacterial pneumonia. Cox survival analysis was used to determine the association of corticosteroids at study entry and as a time-varying covariate, corticosteroid-sparing agents (immunomodulators and antitumor necrosis-alpha [TNF] inhibitors), and pneumococcal vaccination

SUBMITTER: Gregory MH 

PROVIDER: S-EPMC7350553 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature